Antipodes Partners LTD Northrop Grumman Corp Transaction History

Antipodes Partners LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$437.65 - $540.28 $54.3 Million - $67 Million	-124,073 Reduced 59.13%	85,744 $39.6 Million
Q4 2022 Feb 08, 2023	SELL	$464.19 - $549.01 $39.2 Million - $46.4 Million	-84,522 Reduced 28.72%	209,817 $114 Million
Q3 2022 Nov 10, 2022	BUY	$444.65 - $496.46 $43.8 Million - $48.9 Million	98,457 Added 50.26%	294,339 $138 Million
Q2 2022 Aug 12, 2022	SELL	$438.62 - $492.06 $20.3 Million - $22.8 Million	-46,281 Reduced 19.11%	195,882 $93.7 Million
Q1 2022 Apr 21, 2022	SELL	$369.75 - $477.95 $126 Million - $162 Million	-339,561 Reduced 58.37%	242,163 $108 Million
Q4 2021 Apr 21, 2022	BUY	$345.98 - $406.62 $145 Million - $170 Million	419,181 Added 257.89%	581,724 $43.7 Million
Q4 2021 Feb 14, 2022	BUY	$345.98 - $406.62 $56.2 Million - $66.1 Million	162,543 New	162,543 $60.1 Million

1,757

119M

1.12M

1.36M

Ticker NOC
Exchange NYSE
Sector Industrials
Industry Aerospace & Defense
Shares Outstandng 153,912,000
Market Cap $76B
Description
Northrop Grumman Corporation operates as an aerospace and defense company worldwide. The company's Aeronautics Systems segment designs, develops, manufactures, integrates, and sustains aircraft systems. This segment also offers unmanned autonomous aircraft systems, including high-altitude long-endurance strategic ISR systems and vertical take-of...

Get notified when there are updates to the investment portfolio of Antipodes Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Antipodes Partners LTD with notifications on news.